Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (47)Imfinzi approved in EU for early gastric cancer
Preheader (133)Imfinzi approved in the EU as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers
Typography
Arial
Colors
Text Analysis
Body Words137
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px752 px
X-Spam Score1.6
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeEvening

Imfinzi approved in EU for early gastric cancer

Imfinzi approved in the EU as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers
Imfinzi approved in EU for early gastric cancer